NairobiRadiotheranostics
Summit
How to establish radioligand therapy
for advanced cancer care in your region?

Hosted by WHS Regional Meeting

Radiotheranostics is advancing rapidly, offering new hope for cancer patients by combining molecular imaging with targeted radiation to precisely detect and treat tumors. By using a single molecule to both visualize and treat cancer, it eliminates the trial-and-error approach of traditional oncology and spares healthy tissue from unnecessary damage.

For nations, investing in this field isn’t just about advancing science—it means strengthening a key pillar of modern, personalized medicine and improving patient survival. The second Radiotheranostics Summit, organized by the Oncidium foundation, will take place during the World Health Summit (WHS) Regional Meeting 2026 in Nairobi, bringing experts together to accelerate implementation and expand patient access.

Concept
& Landscape

Infrastructure  
& Technology

Clinical:
Experience with Radioligand Therapy

Patient TestImonials
& Case StudIES

Program

What are Radiotheranostics, Products on the global market and what's next.

Speaker to be confirmed

Patient treated during the IAEA National Project- KEN6027 and treating physician

Dr. Harish Nagaraj

Consultant & HOD Nuclear Medicine. Incharge Integrated Molecular Imaging Centre, Kenyatta University Teaching, Referral, and Research Hospital. Adjunct Faculty, University of Nairobi. Oncidium Country Ambassador, KENYA.

National Cancer Control Strategy 2023-2027 and improvement of access to advanced treatment options, including Radioligand Therapy (RLT)

Speaker to be confirmed

Maged Sarhan

Regional Sales Manager (MEA) at CURIUM

Speaker to be confirmed

Watch the first Radiotheranostics Summit, in Dubai

General Information

Innovation, Integration, and Interdependence

The World Health Summit (WHS) Regional Meeting 2026 will be held from April 27–29 at the United Nations Office at Nairobi (UNON). Leaders, innovators, and changemakers will gather to explore solutions that strengthen Africa’s health systems and advance global health progress.

We are honored to be present at this congress with the second edition of the Radiotheranostics Summit, organized by the Oncidium foundation on Tuesday, April 28th, 10:30 AM to 12:00 PM.

Register Today!

Register now

The Oncidium foundation

The Oncidium Foundation is a dedicated nonprofit organization committed to advancing nuclear medicine therapies for cancer care worldwide. Our primary mission revolves around education, awareness, and support for individuals facing the daily battle against cancer, with a focus on those in need of access to the best possible care.

 Through our initiatives and the groundbreaking RLT-Connect platform, we aim to bridge these gaps and provide financial support to patients in underserved regions, ensuring they receive the best possible cancer care. Our dedication to this cause drives us to continue raising awareness, educating, and advocating for equitable access to cutting-edge treatments that offer hope and a chance at longer, better lives for cancer patients worldwide.

Learn more